Welcome to the COPDgene® Study, one of the largest studies ever funded by the National Heart, Lung, and Blood Institute of the National Institutes of Health. The goal of the COPDGene® Study is to understand the genetic epidemiology or underlying genetic factors behind the presence and development of Chronic Obstructive Pulmonary Disease, also known as COPD. Currently, COPD is the third leading cause of death and affects the lives of over 12 million people in the United Sates. The COPDGene® Study is looking for heritable or genetic factors that may be responsible for why some people develop COPD with minimal smoking exposure and others who have high smoking exposure never develop COPD. By better understanding the genetic factors surrounding COPD, we hope to improve the quality of life for COPD patients through the development of new drugs, therapies, and possibly one day a cure.
No further participants are being recruited.
For frequently asked questions on COPDGene® Study Participation, click here.
To get an overview of what a typical study visit looks like, click here.